Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Operating Expenses | 217 | 257 | 0 | 0 | 0 |
| Operating Income | -217 | -257 | N/A | N/A | N/A |
| Interest Expense | 4 | -7 | 0 | 0 | 0 |
| Other Income | -884 | 423 | 0 | 0 | 0 |
| Pre-tax Income | -1,105 | 173 | 0 | 0 | 0 |
| Net Income Continuous | -1,105 | 173 | N/A | N/A | N/A |
| Net Income | $-1,105 | $173 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -0.22 | 0.00 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -0.21 | 0.03 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.22 | 0.00 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.21 | 0.03 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -0.30 | -0.24 | N/A |
| EBITDA(a) | $-217 | $-257 | $N/A | $N/A | $N/A |